Drug use in pregnancy among parous Scandinavian women
DOI:
https://doi.org/10.5324/nje.v11i1.541Sammendrag
SUMMARY
The aim of the present study was to investigate the prevalence of drug use in 1945 parous pregnant Scandinavian
women, to determine the most common drug categories, and to describe changes in drug use throughout
pregnancy. The women were interviewed about drug use by a specially trained midwife at five different occasions
during pregnancy: at gestational week 17, 25, 33, 37, and on admission for delivery at three Scandinavian
study sites (Trondheim, Bergen and Uppsala). When excluding vitamins and iron supplementation, 1086
(56%) women reported at least one episode of drug use during pregnancy, with an average of 2.6 episodes
among the women reporting drug use. Four percent of the women accounted for 18% of the episodes of drug
use. Systemic anti-infectives (15%), respiratory drugs (12%), gastrointestinal drugs (11%) and analgesics
(11%) were the most widely used drugs among all the pregnant women. The number of women using drugs
increased throughout pregnancy.
NORSK SAMMENDRAG
Hensikt med studien var å undersøke forekomsten av legemiddelbruk hos 1945 annen- eller tredjegangs fødende
skandinaviske kvinner, å beskrive hvilke legemiddelgrupper som ble hyppigst brukt, og å beskrive hvordan
legemiddelbruken forandrer seg i løpet av svangerskapet. Kvinnene ble intervjuet av en spesialopplært jordmor
ved fem tidspunkt under svangerskapet: ved gestasjonsuke 17, 25, 33, 37 og ved innleggelse før fødselen
på tre skandinaviske studiesteder (Trondheim, Bergen and Uppsala). Når jern- og vitamintilskudd ekskluderes,
hadde 1086 (56%) av de gravide minst en episode av legemiddelbruk under svangerskapet, med et gjennomsnitt
på 2,6 episoder blant kvinnene som rapporterte legemiddelbruk. Fire prosent av de gravide stod for 18%
av episodene med legemiddelbruk. Systemiske antiinfektiva (15%), legemidler med virkning på respirasjonssystemet
(12%), gastrointestinale legemidler (11%) og analgetika (11%) var de hyppigst brukte legemiddelgruppene.
Andel gravide som rapporterte legemiddelbruk økte i løpet av svangerskapet.
Downloads
Nedlastinger
Publisert
Hvordan referere
Utgave
Seksjon
Lisens
Norsk Epidemiologi licenses all content of the journal under a Creative Commons Attribution (CC-BY) licence. This means, among other things, that anyone is free to copy and distribute the content, as long as they give proper credit to the author(s) and the journal. For further information, see Creative Commons website for human readable or lawyer readable versions.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
